ArticleJTO clinical and research reports2026

Brief Report: Reassessment of bTMB as a Predictive Biomarker in NSCLC Immunotherapy-A Reanalysis of OAK and POPLAR.

Jiaqian Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.